Cargando…

Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case–control study

PURPOSE: Vitamin D pathway single nucleotide polymorphisms (SNPs) are potentially useful proxies for investigating whether circulating vitamin D metabolites [total 25-hydroxyvitamin-D, 25(OH)D; 1,25-dihydroxyvitamin, 1,25(OH)(2)D] are causally related to prostate cancer. We investigated associations...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilbert, Rebecca, Bonilla, Carolina, Metcalfe, Chris, Lewis, Sarah, Evans, David M., Fraser, William D., Kemp, John P., Donovan, Jenny L., Hamdy, Freddie C., Neal, David E., Lane, J. Athene, Smith, George Davey, Lathrop, Mark, Martin, Richard M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298668/
https://www.ncbi.nlm.nih.gov/pubmed/25488826
http://dx.doi.org/10.1007/s10552-014-0500-5
_version_ 1782353275992932352
author Gilbert, Rebecca
Bonilla, Carolina
Metcalfe, Chris
Lewis, Sarah
Evans, David M.
Fraser, William D.
Kemp, John P.
Donovan, Jenny L.
Hamdy, Freddie C.
Neal, David E.
Lane, J. Athene
Smith, George Davey
Lathrop, Mark
Martin, Richard M.
author_facet Gilbert, Rebecca
Bonilla, Carolina
Metcalfe, Chris
Lewis, Sarah
Evans, David M.
Fraser, William D.
Kemp, John P.
Donovan, Jenny L.
Hamdy, Freddie C.
Neal, David E.
Lane, J. Athene
Smith, George Davey
Lathrop, Mark
Martin, Richard M.
author_sort Gilbert, Rebecca
collection PubMed
description PURPOSE: Vitamin D pathway single nucleotide polymorphisms (SNPs) are potentially useful proxies for investigating whether circulating vitamin D metabolites [total 25-hydroxyvitamin-D, 25(OH)D; 1,25-dihydroxyvitamin, 1,25(OH)(2)D] are causally related to prostate cancer. We investigated associations of sixteen SNPs across seven genes with prostate-specific antigen-detected prostate cancer. METHODS: In a nested case–control study (within the ProtecT trial), we estimated odds ratios and 95 % confidence intervals (CIs) quantifying associations between SNPs and prostate cancer. Subgroup analyses investigated whether associations were stronger in men who had high/low sun exposure [a proxy for 25(OH)D]. We quantified associations of SNPs with stage (T1–T2/T3–T4) and grade (<7/≥7). Multiple variant scores included SNPs encoding proteins involved in 25(OH)D synthesis and metabolism. RESULTS: We included 1,275 prostate cancer cases (141 locally advanced, 385 high grades) and 2,062 healthy controls. Vitamin D-binding protein SNPs were associated with prostate cancer (rs4588-A: OR 1.20, CI 1.01, 1.41, p = 0.04; rs7041-T: OR 1.19, CI 1.02, 1.38, p = 0.03). Low 25(OH)D metabolism score was associated with high (vs low) grade (OR 0.76, CI 0.63, 0.93, p = 0.01); there was a similar association of its component variants: rs6013897-A in CYP24A1 (OR 0.78, CI 0.60, 1.01, p = 0.06) and rs10877012-T in CYP27B1 (OR 0.80, CI 0.63, 1.02, p = 0.07). There was no evidence that associations differed by level of sun exposure. CONCLUSION: We found some evidence that vitamin D pathway SNPs were associated with prostate cancer risk and grade, but not stage. There was no evidence of an association in men with deficient vitamin D (measured by having low sun exposure). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10552-014-0500-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4298668
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-42986682015-01-23 Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case–control study Gilbert, Rebecca Bonilla, Carolina Metcalfe, Chris Lewis, Sarah Evans, David M. Fraser, William D. Kemp, John P. Donovan, Jenny L. Hamdy, Freddie C. Neal, David E. Lane, J. Athene Smith, George Davey Lathrop, Mark Martin, Richard M. Cancer Causes Control Original Paper PURPOSE: Vitamin D pathway single nucleotide polymorphisms (SNPs) are potentially useful proxies for investigating whether circulating vitamin D metabolites [total 25-hydroxyvitamin-D, 25(OH)D; 1,25-dihydroxyvitamin, 1,25(OH)(2)D] are causally related to prostate cancer. We investigated associations of sixteen SNPs across seven genes with prostate-specific antigen-detected prostate cancer. METHODS: In a nested case–control study (within the ProtecT trial), we estimated odds ratios and 95 % confidence intervals (CIs) quantifying associations between SNPs and prostate cancer. Subgroup analyses investigated whether associations were stronger in men who had high/low sun exposure [a proxy for 25(OH)D]. We quantified associations of SNPs with stage (T1–T2/T3–T4) and grade (<7/≥7). Multiple variant scores included SNPs encoding proteins involved in 25(OH)D synthesis and metabolism. RESULTS: We included 1,275 prostate cancer cases (141 locally advanced, 385 high grades) and 2,062 healthy controls. Vitamin D-binding protein SNPs were associated with prostate cancer (rs4588-A: OR 1.20, CI 1.01, 1.41, p = 0.04; rs7041-T: OR 1.19, CI 1.02, 1.38, p = 0.03). Low 25(OH)D metabolism score was associated with high (vs low) grade (OR 0.76, CI 0.63, 0.93, p = 0.01); there was a similar association of its component variants: rs6013897-A in CYP24A1 (OR 0.78, CI 0.60, 1.01, p = 0.06) and rs10877012-T in CYP27B1 (OR 0.80, CI 0.63, 1.02, p = 0.07). There was no evidence that associations differed by level of sun exposure. CONCLUSION: We found some evidence that vitamin D pathway SNPs were associated with prostate cancer risk and grade, but not stage. There was no evidence of an association in men with deficient vitamin D (measured by having low sun exposure). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10552-014-0500-5) contains supplementary material, which is available to authorized users. Springer International Publishing 2014-12-09 2015 /pmc/articles/PMC4298668/ /pubmed/25488826 http://dx.doi.org/10.1007/s10552-014-0500-5 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Original Paper
Gilbert, Rebecca
Bonilla, Carolina
Metcalfe, Chris
Lewis, Sarah
Evans, David M.
Fraser, William D.
Kemp, John P.
Donovan, Jenny L.
Hamdy, Freddie C.
Neal, David E.
Lane, J. Athene
Smith, George Davey
Lathrop, Mark
Martin, Richard M.
Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case–control study
title Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case–control study
title_full Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case–control study
title_fullStr Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case–control study
title_full_unstemmed Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case–control study
title_short Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case–control study
title_sort associations of vitamin d pathway genes with circulating 25-hydroxyvitamin-d, 1,25-dihydroxyvitamin-d, and prostate cancer: a nested case–control study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298668/
https://www.ncbi.nlm.nih.gov/pubmed/25488826
http://dx.doi.org/10.1007/s10552-014-0500-5
work_keys_str_mv AT gilbertrebecca associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy
AT bonillacarolina associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy
AT metcalfechris associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy
AT lewissarah associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy
AT evansdavidm associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy
AT fraserwilliamd associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy
AT kempjohnp associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy
AT donovanjennyl associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy
AT hamdyfreddiec associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy
AT nealdavide associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy
AT lanejathene associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy
AT smithgeorgedavey associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy
AT lathropmark associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy
AT martinrichardm associationsofvitamindpathwaygeneswithcirculating25hydroxyvitamind125dihydroxyvitamindandprostatecanceranestedcasecontrolstudy